Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)

CompletedOBSERVATIONAL

Enrollment

1,296

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions

Benign Prostatic Hyperplasia

Interventions

OTHER

Patients with Benign Prostate Hyperplasia

patients with benign prostatic hyperplasia under fixed dose combΙnation treatment with dutasteride and tamsulosin

Trial Locations (1)

Laikon Hospital of Athens, Athens